Friday, Jan 26, 2024 · SEC filings

What the smart money revealed on Jan 26

Real insider buys19insiders · $8.11M
Real insider sales34insiders · $55.7M
Fund 13Fs filed—not loaded for this day
Activist 13Ds filed—not loaded for this day

487 insider filings came in. We hid 40 planned (10b5-1) sellers and 369 people whose filings were routine, like grants and tax withholding.

trending_up

Adicet Bio (ACET) Director Carl Gordon bought $7.5M

3.12M shares on the open market. Not a grant or an option exercise. Their past buys: 2 of 3 checked quarters beat the typical stock 6 months later.

Real buy Form 4 Past buys: 2 of 3 beat Traded Jan 25
$7.5M
trending_up

Texas Capital Bancshares (TCBI) Director Robert Stallings bought $171K

9,000 shares on the open market. Not a grant or an option exercise. Their past buys: 7 of 9 checked quarters beat the typical stock 6 months later.

Real buy Form 4 Past buys: 7 of 9 beat Traded Jan 24–25
$171K
trending_up

Perspective Therapeutics (CATX) Chief Medical Officer Markus Puhlmann bought $140K

280,000 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Jan 24
$140K
trending_up

Texas Capital Bancshares (TCBI) Director Laura Whitley bought $125K

2,000 shares on the open market. Not a grant or an option exercise.

Real buy Form 4 Traded Jan 25
$125K
trending_down

Procter & Gamble (PG) Chief Brand Officer Marc Pritchard sold $15.6M

Not marked as a planned 10b5-1 sale. Most of the shares sold came from stock options they exercised the same day. Still holds 163,428 shares directly.

Real sale Form 4 Traded Jan 24
$15.6M
trending_down

Procter & Gamble (PG) CEO - Baby Ma. Francisco sold $11.4M

Not marked as a planned 10b5-1 sale. Most of the shares sold came from stock options they exercised the same day. Still holds 973 shares directly.

Real sale Form 4 Traded Jan 24
$11.4M
trending_down

Sempra (SRE) Chairman Jeffrey Martin sold $2.42M

Not marked as a planned 10b5-1 sale. Sold 100% of the shares they held directly. Still holds 2 shares.

Real sale Form 4 Sold 100% of stake Traded Jan 26
$2.42M
Show 15 more real buys
Show 31 more real sales
PG Procter & Gamble · COO Shailesh Jejurikar · Traded Jan 25
$4.84M
MS Morgan Stanley · Executive Chairman James Gorman · Traded Jan 26
$4.4M
PG Procter & Gamble · Chief Human Resources Officer Balaji Purushothaman · Traded Jan 25
$2.16M
TEAM Atlassian · Co-CEO Michael Cannon-Brookes · Traded Jan 25
$2.01M
TEAM Atlassian · Co-CEO Scott Farquhar · Traded Jan 25
$2.01M
KURA Kura Oncology · President and CEO Troy Wilson · Traded Jan 24
$1.84M
WMT Walmart · President and CEO C. Douglas McMillon · Traded Jan 25
$1.56M
SCHW Charles Schwab · Co-Chairman Charles Schwab · Traded Jan 24
$1.05M
FUL Fuller H B · Sr. VP Heather Campe · Traded Jan 24
$1.02M
HWC Hancock Whitney · COO D. Shane Loper · Traded Jan 25
$828K
WABC Westamerica Bancorporation · Chairman David Payne · Traded Jan 25
$746K
S SentinelOne · CPO and CTO Ric Smith · Traded Jan 25
$639K
TRV Travelers Companies · EVP and Chief HR Officer Diane Kurtzman · Traded Jan 25
$633K
SLG Sl Green Realty · Director Betsy Atkins · Traded Jan 26
$467K
KMB Kimberly Clark · President Tristram Wilkinson · Traded Jan 26
$450K
RBLX Roblox · Director Gregory Baszucki · Traded Jan 24
$343K
GSBC Great Southern Bancorp · Director Thomas Carlson · Traded Jan 25
$271K
WBS Webster Financial · Head of HSA Bank Charles Wilkins · Traded Jan 25
$204K
CBSH Commerce Bancshares · Executive Vice President John Handy · Traded Jan 25
$142K
GBX Greenbrier Companies · EVP and President Brian Comstock · Traded Jan 25
$116K
AMK AssetMark Financial · EVP Joel McNatt Jr. · Traded Nov 17 · Filed late
$101K
AGNC AGNC Investment · EVP Bernice Bell · Traded Jan 26
$98.5K
SMPL Simply Good Foods · Director Robert Montgomery · Traded Jan 25
$98.4K
HHH Howard Hughes · Director Anthony Williams · Traded Jan 4 · Filed late
$70.5K
WBS Webster Financial · Chief Risk Officer Daniel Bley · Traded Jan 25
$63.6K
SOTK Sono Tek · Director Joseph Riemer · Traded Jan 24–26
$36.9K
TER Teradyne · President Richard Burns · Traded Jan 25
$35.7K
NVEC NVE · Director Terrence Glarner · Traded Jan 25
$21.6K
EQBK Equity Bancshares · EVP Julie Huber · Traded Feb 9–23 · Filed late
$18.8K
NPCE NeuroPace · Chief Medical Officer Martha Morrell · Traded Jan 24–25
$12.4K
CPK Chesapeake Utilities · Director Thomas Hill Jr. · Traded Jan 16
$714

13F season

Holdings as of Dec 31, 2023 are due Feb 14

49 funds have filed so far. 40 filed for the quarter before.

Biggest real insider buys, Jan 20–26

Open-market buys by officers and directors, filed in the 7 days up to Jan 26.

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate. Daily closing prices come from post-no-preference/stocks on DoltHub, a community-run database shared under CC BY-SA 4.0; the prices we show stay under that license. They are each day's close, not live or official exchange prices.

This is data, not investment advice. About StockToast · Your watchlist